Fundraising FoxAtlas Venture — 2019 Investments
7 investments dated 2019 · listed companies and verified rows first · show all
Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.
BiotechHealthtechCambridge, US
Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJean-François Formela(Director)inOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRam Aiyar(Chief Executive Officer, President and Director)inTodd Chappell(Chief Operating Officer)in
Board seatJean-François Formela· per SEC Form D
Co-investorsMC Healthcare VenturesNew Enterprise Associates (NEA)AlexandriaQiming Venture PartnersQiming Venture Partners USARock Springs Capital+3 more
Egalet develops medicines for people living with moderate to severe pain, including approved and licensed pain products.
BiotechHealthtechMedical DevicesWayne, US
BARBARA A. CARLIN(SENIOR VICE PRESIDENT AND CHIEF ACCOUNTING OFFICER)ROBERT S. RADIE(CHIEF EXECUTIVE OFFICER)MARK STROBECK(EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER)MEGAN TIMMINS(SENIOR VICE PRESIDENT AND GENERAL COUNSEL)PATRICK M. SHEA(SENIOR VICE PRESIDENT AND CHIEF COMMERCIAL OFFICER)Jeffrey M. Dayno(Chief Medical Officer)
Co-investorsSunstone Capital
Co-investorsBain Capital Life SciencesGeneral AtlanticOrbiMed
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
IFM CinqueIFM ContinuaIFM QuattroTriplet Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.